Based on an academic paper published in the Journal of Medicinal Chemistry, research indicates that asthma treatment in the future will target allergens like dust mites. In 'The Discovery of Potent, Selective and Reversible Inhibitors of the House Dust Mite Peotidase Allergen Der p 1: An Innovative Approach to the Treatment of Allergic Asthma' scientists from Cambridge, the University of London and Manchester discuss trigger allergens. The result is a powder you can inhale made from a compound that attaches itself to a major dust mite allergen. This product could change asthma treatment by inhibiting it rather than offering relief.
Instead of relaxing affected muscles so asthma sufferers can breath easily, this new development tries to cut off the allergic reaction from the get go. This experiment is only the starting point.